Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 3/20 | 0.79 |
| ▸ | GSK3B | P49841 | 3/20 | 0.79 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.65 |
| ▸ | PIM1 | P11309 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 6/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | GFER | P55789 | 1/20 | 0.58 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | RECQL | P46063 | 4/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12990771 | 1.00 | GSK3A (0.79) | GSK3AGSK3BPIK3CGPIM1POLB | |
| SCHEMBL3365346 | 1.00 | GSK3A (0.79) | GSK3AGSK3BPIK3CGPIM1POLB | |
| SCHEMBL5143164 | 0.88 | GSK3A (1.00) | GSK3AGSK3BPIK3CGPIM1POLB | |
| SCHEMBL5143166 | 0.88 | GSK3A (1.00) | GSK3AGSK3BPIK3CGPIM1POLB | |
| SCHEMBL3362480 | 0.85 | GSK3A (0.77) | GSK3AGSK3BPOLBTDP1ALDH1A1 | |
| SCHEMBL3362481 | 0.85 | GSK3A (0.77) | GSK3AGSK3BPOLBTDP1ALDH1A1 | |
| SCHEMBL12990390 | 0.85 | GSK3A (0.77) | GSK3AGSK3BPOLBTDP1ALDH1A1 | |
| SCHEMBL13587005 | 0.80 | GSK3A (0.81) | GSK3AGSK3BPIK3CGPIM1POLB | |
| SCHEMBL5143410 | 0.79 | PPM1G (0.62) | GSK3AGSK3BPIK3CGPOLBTDP1 | |
| SCHEMBL5143032 | 0.79 | POLB (0.65) | GSK3AGSK3BPIK3CGPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100331315-A1 | RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS | SENHWA BIOSCIENCES, INC. (TW) | 2010-12-30 | — | — | US | disclosed |
| WO-2010148351-A1 | RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS | CYLENE PHARMACEUTICALS, INC. (US) | 2010-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331315-A1 | RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS | PIM2, PIM1, CDK2 | GSK3A 412/4885GSK3B 375/4885PIK3CG 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.